NEW YORK--(BUSINESS WIRE)-- Kirby McInerney LLP is investigating potential claims against InterMune, Inc. (“InterMune” or the “Company”) (NASDAQ:ITMN) concerning the proposed acquisition of the Company by Roche Holding AG (SIX:RO, ROG; OTCQX:RHHBY). Under the terms of the definitive merger agreement, InterMune stockholders will receive $74.00 in cash for each share of InterMune common stock they own, valuing the transaction at approximately $8.3 billion.
The investigation concerns whether the InterMune Board of Directors violated its fiduciary duties by agreeing to the proposed transaction and whether the proposed consideration adequately values the Company’s common stock.
If you are an InterMune stockholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at email@example.com or telephone at (212) 699-1145, or toll free at (888) 529-4787, or by filling out this contact form. There is no cost or obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating in securities, stockholder, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.
Kirby McInerney LLP
J. Brandon Walker, Esq., 212-699-1145
Source: Kirby McInerney LLP